BAIA
IDXX icon

Bel Air Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bel Air Investment Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-624
Closed -$305K – 439
2021
Q1 		$305K Buy
+624
New +$313K 0.01% 325

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bel Air Investment Advisors's IDXX Position: Q2 2021 in Review

Bel Air Investment Advisors sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 624 shares — an estimated $305K sold.

Bel Air Investment Advisors first reported a position in IDXX in Q1 2021 and held it in 1 quarter. The position peaked at $305K in Q1 2021. 1,033 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

  • Bel Air Investment Advisors reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
  • Bel Air Investment Advisors sold 624 Idexx Laboratories shares in Q2 2021, an estimated $305K.
  • Bel Air Investment Advisors first reported a position in Idexx Laboratories in Q1 2021 and held it in 1 quarter.
  • Bel Air Investment Advisors's Idexx Laboratories position peaked at $305K in Q1 2021.
  • 1,033 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Bel Air Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.